Key result
Standardized HF center care is linked to ~70% lower 1-year mortality in chronic heart failure.
Why the study?
Heart failure is harmful to health and economics, and standardized heart failure management centers were developed to correct non-standardized treatment, but their impact on chronic heart failure management and prognosis required evaluation.
Does the construction of a standardized heart failure management center improve treatment standardization and prognosis in patients with chronic heart failure?
Cohort (n=263)
No
Does the construction of a standardized heart failure management center improve treatment standardization and prognosis in patients with chronic heart failure?
The implementation of a standardized heart failure management center significantly improved the utilization of guideline-directed medical therapies and was associated with reduced 1-year all-cause mortality and readmission rates in patients with chronic heart failure.
Answers are grounded in this paper and cite their sources.
May support standardized HF centers; extends single-center data but leaves open causality and generalizability.
BACKGROUND: Heart failure is extremely harmful to human health and social economics. The purpose of standardized heart failure management center (SHFMC) is to correct the non-standardization of heart failure treatment. HYPOTHESIS: SHFMC has a positive impact on the management and prognosis of patients with chronic heart failure (CHF). METHODS: The SHFMC database of Jiaxing First Hospital was retrospectively analyzed. Two hundred sixty-three patients with CHF who were hospitalized in the cardiovascular medicine department of Jiaxing First Hospital in Zhejiang Province from January 2020 to December 2020 were identified as study subjects. The SHFMC opening day, July 1, 2020, was used as the dividing line around which the patients were divided into Group A (before the completion of SHFMC, n = 137) and Group B (after, n = 126). The baseline data, treatment standardization, long-term efficacy, 1-year all-cause mortality, and readmission rate of the two groups were compared. RESULTS: The use of angiotensin receptor enkephalinase inhibitors (ARNIs), β-blockers (β-Bs), and sodium-glucose cotransport protein 2 inhibitors (SGLT2is) increased significantly, and the long-term outcome, readmission rate, and 1-year all-cause mortality of patients improved in group B. CONCLUSIONS: The construction of SHFMC has been associated with consistent improvements in the standardization of CHF treatment, long-term patient outcomes, 1-year cumulative survival rates, and readmission rates.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) conducted a cohort in Chronic heart failure (n=263). Standardized heart failure management center (SHFMC) vs. Usual care before SHFMC construction was evaluated on 1-year all-cause mortality (p=<0.05). Implementation of a standardized heart failure management center significantly reduced 1-year all-cause mortality from 23% to 7% and readmission rates from 63% to 39% in patients with chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: